HSA · registration DE0018388Siemens N Antisera to Human Apolipoprotein A-II and Apolipoprotein E
- Registration number
- DE0018388
- Model name
- N Apolipoprotein A-II Kit; N Apolipoprotein E Kit; N Reaction Buffer; N Diluent; N Apolipoprotein Standard Serum; Apolipoprotein Control Serum CHD (human)
- Model identifier
- OQBA09; OQDL09; OUMS61; OUMT05; OUPG07; OUPH07
- Registration date
- July 20, 2016
- Source update date
- October 01, 2024
- Risk class
- Class B
- Product owner
- Siemens Healthcare Diagnostics Products GmbH
- Registrant / registration holder
- SIEMENS HEALTHCARE PTE. LTD.
N APOAII is an in vitro diagnostic reagent for the quantitative IFCC-standardized determination of apolipoprotein A-II (Apo A-II) as an aid in the assessment of high-density lipoprotein (HDL) metabolism defects related to cardiovascular disease and arteriosclerosis in human serum by means of automated Siemens Healthineers immuno- nephelometry systems. N APOE is an in vitro diagnostic reagent for the quantitative determination of apolipoprotein E (Apo E) in human serum as an aid to diagnosis for congenital hyperlipoproteinemia by means of automated Siemens Healthineers immuno-nephelometry systems.
- Product owner address
- Emil-von-Behring-Str. 76, 35041 Marburg, Germany
- Registrant address
- 60 MACPHERSON ROAD, THE SIEMENS CENTRE, Singapore 348615
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.